Clinical Trial Update: Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia [Phase 4]

View source ↗

Summary

Phase 4 trial of Valbenazine (Ingrezza) for cervical dystonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• INGREZZA (valbenazine)

Snippet

Sponsor: The Orthopedic Foundation | Conditions: Cervical Dystonia | Phase 4 | Status: COMPLETED